A webcast presentation will be held by
The interim report and the presentation to be used in the webcast are available on the
The interim report and the presentation are attached to this notice (as .pdf files), IDEX 2022 Q3 Interim Report - pub, IDEX 2022 Q3 Presentation - pub
Commercial Update
2022 has become a year of broad-based commercialization for biometric smart cards. In our primary target market, many banks have begun, or are planning, launches and commercialization of biometric payment cards. During the year, the rapidly increasing demand for cyber security, digital authentication, and crypto currency cold wallet solutions has sparked a wave of new applications and use cases for biometric smart cards.
In the payments space, we expect to have a total of 10 launches this year, or by early 2023, from banks and issuers together with card-maker
We now have 9 design wins with card makers for our Infineon SLC38 reference platform and Turnkey Solution. During the quarter, six of these card makers have already placed initial orders for IDEX sensors. We also continue to see rapidly increasing demand for IDEX biometric security solutions for use in digital authentication, cyber security, and digital HASHwallets, to facilitate adoption of Web3 and digital assets.
In September we held a capital markets day in
Third Quarter Financial Performance
For the third quarter ended
Gross profit margin, as a percentage of revenue, was approximately 12% for the third quarter of 2022, compared sequentially to approximately 7% in the second quarter of 2022. For the third quarter of 2021, a similarly calculated gross profit margin was approximately 59%, with the higher figure reflecting sales mix. The lower margins in 2022 reflect a shift in mix to lower margin payment card products and higher costs of wafers, assembly services, and certain components, as well as the write-off of previous-generation products held in inventory.
Net loss for the third quarter of 2022 totaled (
The company’s cash balance totaled
For further information contact:
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186
About
For more information, visit www.idexbiometrics.com
TRADEMARK STATEMENT
IDEX,
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachments
- IDEX 2022 Q3 Interim Report - pub
- IDEX 2022 Q3 Presentation - pub
Source:
2022 GlobeNewswire, Inc., source